期刊文献+

呼出气一氧化氮检测对支气管哮喘的诊断意义 被引量:6

Fractional exhaled nitric oxide in the diagnosis of bronchial asthma
下载PDF
导出
摘要 目的:探讨呼出气一氧化氮(fractional exhaled nitric oxide,FeNO)对支气管哮喘的诊断意义。方法:纳入郑州大学人民医院呼吸与危重症医学科门诊与病房有喘息、气急、胸闷、咳嗽等疑似支气管哮喘患者97例,以支气管激发试验或舒张试验为诊断金标准,绘制受试者工作特征(ROC)曲线,结合ROC曲线评估FeNO对哮喘诊断的价值,并得出最佳界值。结果:97例患者中61例最终诊断为哮喘,36例为非哮喘。哮喘组FeNO高于非哮喘组[(42.2±25.0)ppb比(24.9±15.3)ppb,P<0.05]。FeNO与FEV1/FVC%(一秒率)无直线相关性(r=0.098,P=0.596)。ROC曲线下面积是0.810,FeNO最佳界值为27.5 ppb,以该点为界值,诊断哮喘的敏感度为83.6%,特异度为77.8%。结论:FeNO诊断哮喘有较高的敏感性与特异性,结合肺功能检测可以降低其漏诊率。 Objective: To explore the value of fractional exhaled nitric oxide(FeNO) in the diagno- sis of bronchial asthma. Methods: 97 patients with suspected bronchial asthma from department of respiratory medicine in People' s Hospital of Zhengzhou University were selected. Bronchial provocation or dilation tests were defined as golden standards for diagnosis of bronchial asthma. The diagnostic value of FeNO was assessed and the optimal critical value was determined by receiver operating characteristic(ROC) curves. Results: Among 97 patients,61 patients had final diagnosis as bronchial asthma. The remained 36 cases were diagnosed as non-asthma. The levels of FeNO in asthma group were higher than non-asthma group [ (42.2 ±25.0) ×10-9 mol/L VS (24.9 ± 15.3 ) × 10-9 mol/L,P 〈 0.05 ]. There was no significant correlation between FeNO and FEV1/FVC% in patients with asthma(r = 0. 098, P 〉 0.05 ). Area under ROC curve was 0. 810. The optimal critical value of FeNO was 27.5 ppb. The diagnostic sensitivity of bronchial asthma was 83.6% and the specificity was 77.8% according to this critical value. Conclusion : FeNO test have high sensitivity and specificity in the diagnosis of asthma, and the missed diagnosis rate may be decreased by combining with pulmonary function test.
出处 《河南医学研究》 CAS 2014年第1期23-25,共3页 Henan Medical Research
关键词 哮喘 呼出气一氧化氮 支气管激发试验 ROC曲线 诊断 bronchial asthma fractional exhaled nitric oxide bronchial provocation test receiver operating characteristic curve diagnosis
  • 相关文献

参考文献5

  • 1American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide[J]. AmJRespirCrit CareMed, 2005, 171(8) :912-930.
  • 2Miller M R, Hankinson J, Brusasco V, et al. Standardisation of spi- rometry[ J]. Eur Respir, 2005, 26:219-338.
  • 3中华医学会呼吸病学会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗管理方案)[J].中国结核呼吸杂志,2008,31(3):177-185.
  • 4王雯,王辰.支气管哮喘患者呼出气一氧化氮浓度监测的临床意义[J].中国医刊,2007,42(12):3-5. 被引量:44
  • 5Dupont L J, Demedts M G, Verteden G M,et al. Prospective evalua- tion of the validity of exhaled nitric oxide for the diagnosis of asthma [J]. Chest, 2003, 123(3) :751-756.

共引文献43

同被引文献80

  • 1姚慧娟,张悦鸣,李志奎.呼出气一氧化氮检测诊断支气管哮喘[J].中华哮喘杂志(电子版),2013,7(3):10-14. 被引量:6
  • 2夏清,潘频华,王展,陆蓉莉,胡成平.呼出气一氧化氮检测在支气管炎症性肺疾病中的临床应用[J].中南大学学报(医学版),2014,39(4):365-370. 被引量:48
  • 3American Thoracic Society, European Respiratory Society. ATS!ERS recommendations for standardized proceduresfor the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide [ J ]. Am JRespir Crit Care Med, 2005, 171:912 - 30.
  • 4Patelis A, Gunnbjornsdottir M, Andrei alinovsehi A, et al. Popula- tion-based study of multiplexed IgE sensitization in relation to asthma,exhaled nitric oxide,and bronchial Responsiveness[ J]. J Allergy ClinImmunol, 2012,130:397 - 402.
  • 5Hsu JY, Wang CY, Cheng YW, et al. Optimal value of fractional exhaled nitric oxide in inhaled corticosteroid treatment for patients with chronic cough of unknown cause [ J ]. J Chin Med Assoc, 2013,76(1) :15 -19.
  • 6Woo S,Lee J,Kim H,et al. Utility of fractional exhalednitric oxide (FeNO) measurements in diagnosing asthma[ J]. Respiratory Med- icine, 2012,106:1103 - 1109.
  • 7Taylor DR, Pijnenburg MW, Smith AD, et al. Exhaled nitric ox- ide measurements : clinical application and interpretation [J]. Tho- rax ,2006,61:817 - 827.
  • 8Lehouck A, Carrem ans C, De Bent K, et al. Alveolar and bron- chial exhaled nitric oxide in chronic obstructive pulm onary disease [J]. Respir M ed, 2010, 104(7) : 1020 -1026.
  • 9Perez-de-Llano LA, Carballada F, Castro Anon O, et al. Exhaled nitrie oxide predicts control in patients with difficult-to-treat asthma [ J ]. Eur Respir J,2010,35 : 1221 - 1227.
  • 10Smith AD, cowan JO, brassrtt KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma [ J ]. N Engl J Med ,2005,352 : 2163 - 2173.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部